These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Women's health issues. Kaiser FE Med Clin North Am; 2003 Sep; 87(5):xi-xiii. PubMed ID: 14621323 [No Abstract] [Full Text] [Related]
23. Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Miller AP; Chen YF; Xing D; Feng W; Oparil S Hypertension; 2003 Oct; 42(4):657-63. PubMed ID: 12913055 [TBL] [Abstract][Full Text] [Related]
24. Non-genomic vascular actions of female sex hormones: physiological implications and signalling pathways. Leung SW; Teoh H; Keung W; Man RY Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):822-6. PubMed ID: 17600565 [TBL] [Abstract][Full Text] [Related]
25. Hormones and cardiovascular health in women. ESHRE Capri Workshop Group Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276 [TBL] [Abstract][Full Text] [Related]
26. Cardiovascular aspects of menopausal hormone replacement therapy. Rosano GM; Vitale C; Fini M Climacteric; 2009; 12 Suppl 1():41-6. PubMed ID: 19811240 [TBL] [Abstract][Full Text] [Related]
27. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view. Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877 [TBL] [Abstract][Full Text] [Related]
28. Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women. White RE; Gerrity R; Barman SA; Han G Steroids; 2010 Nov; 75(11):788-93. PubMed ID: 20060403 [TBL] [Abstract][Full Text] [Related]
29. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Iorga A; Cunningham CM; Moazeni S; Ruffenach G; Umar S; Eghbali M Biol Sex Differ; 2017 Oct; 8(1):33. PubMed ID: 29065927 [TBL] [Abstract][Full Text] [Related]
30. Estrogens and Coronary Artery Disease: New Clinical Perspectives. Meyer MR; Barton M Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102 [TBL] [Abstract][Full Text] [Related]
31. Sex hormones and the cardiovascular system: effects on arterial function in women. Teede HJ Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228 [TBL] [Abstract][Full Text] [Related]
32. Mining the complexities of the estrogen signaling pathways for novel therapeutics. McDonnell DP Endocrinology; 2003 Oct; 144(10):4237-40. PubMed ID: 14500558 [No Abstract] [Full Text] [Related]
33. Hormone replacement therapy and cardiovascular health in midlife women. Sharts-Hopko NC Medsurg Nurs; 1995 Aug; 4(4):314-6. PubMed ID: 7627237 [No Abstract] [Full Text] [Related]
34. Hormone in the hot seat. Mandavilli A Nat Med; 2006 Jan; 12(1):8-9. PubMed ID: 16397539 [No Abstract] [Full Text] [Related]
35. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results. Kuhl H; Stevenson J Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155 [TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effects of tanshinone IIA on atherosclerostic vessels of ovariectomized ApoE mice are mediated by estrogen receptor activation and through the ERK signaling pathway. Liu X; Guo CY; Ma XJ; Wu CF; Zhang Y; Sun MY; Pan YT; Yin HJ Cell Physiol Biochem; 2015; 35(5):1744-55. PubMed ID: 25832326 [TBL] [Abstract][Full Text] [Related]
37. Postmenopausal hormone therapy and cardiovascular disease in women. Stefanick ML Nutr Metab Cardiovasc Dis; 2010 Jul; 20(6):451-8. PubMed ID: 20554177 [TBL] [Abstract][Full Text] [Related]
38. Modulation of cardiac hypertrophy by estrogens. Pelzer T; Shamim A; Wölfges S; Schumann M; Neyses L Adv Exp Med Biol; 1997; 432():83-9. PubMed ID: 9433514 [TBL] [Abstract][Full Text] [Related]